Telmisartan Dispersible Tablets Market
Telmisartan Dispersible Tablets Market Size, Share, and Trends Analysis Report, By Product Type (80 mg and 40 mg), By Application (Online Sales and Offline Sales), Forecast (2022-2028) Update Available - Forecast 2024-2030
Telmisartan dispersible tablets market is anticipated to grow at a CAGR of 3.2% during the forecast period. Telmisartan dispersible tablets are the type of medications used to treat high blood pressure (hypertension). Telmisartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so blood can flow more easily. The rising incidence of hypertension globally is the major factor accelerating the growth of the global telmisartan dispersible tablets market. In addition, rising expenditure on health, an increase in cardiovascular diseases, and growing tobacco users are fueling the growth of the market.
According to WHO (World Health Organization), more than 1.13 billion people are suffering from hypertension globally, among them, only 1 in each 5 is cured or under control. Among global mortality cases records, hypertension shares 12.8% of all, which means 7.5 billion mortality cases are recorded due to high blood pressure or hypertension. However, the market growth can be hampered by the lack of awareness regarding the use of antihypertensive drugs such as telmisartan dispersible tablets among the population living in rural areas. Apart from these, the introduction of novel drug/therapeutic compounds with disease-modifying capabilities and better effectiveness by major players can bring new growth opportunities to the market during the forecast period.
Segmental Outlook
The global telmisartan dispersible tablets market is segmented based on product type and application. Based on product type, the market is segmented into 80 mg and 40 mg. Among these, the 40 mg segment is expected to gain potential share in terms of revenue in the market. Telmisartan 40 mg tablet is a medicine used to treat high blood pressure. This medicine also reduces the risk of heart attack and stroke by lowering blood pressure. It can also be used in diabetics to protect kidney function and prevent further damage. The usual effective dose for hypertension is 40 mg which can be taken once daily. In cases where the target blood pressure is not achieved, the dose of telmisartan can be increased to a maximum of 80 mg once daily. The effect of Telmisartan 40 mg tablet can be observed within 1 to 2 hours of intake. Based on application, the market is segmented into online sales and offline sales.
Regional Outlook
Geographically, the market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). In 2021, North America region dominated the market. The region is further projected to maintain its dominance during the forecast period. The regional growth is also driven by the easy availability of hypertension drugs such as telmisartan dispersible tablets and the rise in the geriatric population owing to which there is a significant increase in incidences of hypertension is contributing to the growth of the market.
Global Telmisartan Dispersible Tablets Market Growth, By Region 2022-2028
Asia-Pacific Emerged as Fastest Growing in the Global Telmisartan Dispersible Tablets Market
Geographically, the Asia-Pacific region is likely to be the fastest-growing telmisartan dispersible tablets market during the forecast period. The regional growth is attributed to the rising prevalence of high blood pressure (hypertension). Chronic conditions such as kidney and hormone problems, diabetes, and high cholesterol are the major cause of hypertension. Significant prevalence of such diseases among the population is expected to generate potential demand for telmisartan dispersible tablets. South-East-Asia-region ranked third in the prevalence of diabetes in 2019 with India ranking second to China. The prevalence of diabetes is projected to rise by the year 2045, with a nearly equal proportion in high-income (11.9%) and middle-income (11.8%) countries; and 4.7% in low-income countries, thereby driving the market growth. Besides, the growing number of supportive government policies for hypertension management has also surged the demand for telmisartan dispersible tablets in the region.
Market Players Outlook
The major players operating in the global telmisartan dispersible tablets market include Abbott Laboratories, Bayer AG, and Pfizer, Inc., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global telmisartan dispersible tablets market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Recovery Scenario of Global Telmisartan Dispersible Tablets Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Telmisartan Dispersible Tablets Market by Product Type
4.1.1. 80 mg
4.1.2. 40 mg
4.2. Global Telmisartan Dispersible Tablets Market by Distribution Channel
4.2.1. Online Sales
4.2.2. Offline Sales
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East & Africa
6. Company Profiles
6.1. Abbott Laboratories
6.2. Astellas Pharma Inc.
6.3. Bayer AG
6.4. Beijing Wansheng Pharmaceutical
6.5. Boehringer Ingelheim Ltd.
6.6. Dr. Reddy’s Laboratories Ltd
6.7. GSK Plc
6.8. Hema Pharmaceuticals Pvt. Ltd.
6.9. Mylan N.V.
6.10. Novartis AG
6.11. Pfizer, Inc.
6.12. Takeda Pharmaceutical Co. Ltd.
6.13. Teva Pharmaceutical Industries Ltd.
1. GLOBAL TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
2. GLOBAL 80 MG TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL 40 MG TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
5. GLOBAL TELMISARTAN DISPERSIBLE TABLETS BY ONLINE SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL TELMISARTAN DISPERSIBLE TABLETS BY OFFLINE SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. NORTH AMERICAN TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
9. NORTH AMERICAN TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
10. NORTH AMERICAN TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
11. EUROPEAN TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. EUROPEAN TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
13. EUROPEAN TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
14. ASIA-PACIFIC TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. ASIA-PACIFIC TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
17. REST OF THE WORLD TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. REST OF THE WORLD TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
19. REST OF THE WORLD TELMISARTAN DISPERSIBLE TABLETS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
1. GLOBAL TELMISARTAN DISPERSIBLE TABLETS MARKET SHARE BY PRODUCT TYPE, 2021 VS 2028 (%)
2. GLOBAL TELMISARTAN DISPERSIBLE TABLETS MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
3. GLOBAL TELMISARTAN DISPERSIBLE TABLETS MARKET SHARE BY REGION, 2021 VS 2028 (%)
4. GLOBAL 80 MG TELMISARTAN DISPERSIBLE TABLETS MARKET SHARE BY REGION, 2021 VS 2028 (%)
5. GLOBAL 40 MG TELMISARTAN DISPERSIBLE TABLETS MARKET SHARE BY REGION, 2021 VS 2028 (%)
6. GLOBAL TELMISARTAN DISPERSIBLE TABLETS FROM ONLINE SALES MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL TELMISARTAN DISPERSIBLE TABLETS FROM OFFLINE SALES MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. US TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
9. CANADA TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
10. UK TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
11. FRANCE TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
12. GERMANY TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
13. ITALY TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
14. SPAIN TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
15. REST OF EUROPE TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
16. INDIA TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
17. CHINA TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
18. JAPAN TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
19. SOUTH KOREA TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
20. REST OF ASIA-PACIFIC TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
21. REST OF THE WORLD TELMISARTAN DISPERSIBLE TABLETS MARKET SIZE, 2021-2028 ($ MILLION)
